Gaviscon 24 Sachets 500+267mg/10ml,Gaviscon 24 Bustine 500+267mg/10ml,RECKITT BENCKISER HEALTHCARE (ITALIA) S.P.A.

“Contraindications
Hypersensitivity to the active substance or any of the excipients such as hydroxybenzoate (E218) and propyl paraidrossibenzoato (E216) (parabens).
Dosage
Chewable tablets (strawberry and mint flavor) Dosage Adults and adolescents (12-18 years): 1-2 tablets 500 mg + 267 mg after meals and before bedtime. 2-4 tablets of 250 mg + 133.5 mg after meals and before bed. Directions for use For oral administration. The tablets should be chewed well (you can break them off and chew a little at a time). You can drink some water later. Oral suspension Dosage for Adults and adolescents (12-18 years): 10-20 ml (second to fourth groove of measuring spoon or 2-4 measuring spoons or 1-2 single-dose sachets) after meals and before bedtime. Directions for use For oral administration. Shake the suspension before use. Oral Powder Dosage Adults and adolescents (12-18 years): 1-2 sachets per serving after meals and at bedtime. Method of administration: Take the drug orally without water. Special Populations Elderly: No dose adjustment is required for this age group. Patients with renal failure: Decreased ability to excrete urinary salt supplementation with antacids may affect electrolyte imbalances in a potentially severe manner.
Warnings
Do not use for long-term treatment. In adolescents (12-18 years old) use only if really necessary and under the strict supervision of a physician. Renal failure In cases of renal failure, the drug should be used with caution, since the addition of exogenous salts with antacids may result in potentially serious electrolyte imbalances. Each 500 mg + 267 mg tablet contains 123 mg (5.3 mmol) sodium. Each 250 mg +133.5 mg tablet contains 61.5 mg (2.65 mmol) sodium. Each dose of 10 ml of suspension contains 141 mg (6.2 mmol) sodium. Each sachet of single dose oral powder 500 mg + 267 mg contains 123 mg (5.3 mmol) sodium. This should be taken into account in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure and impaired renal function. Each 500 mg + 267 mg tablet contains 160 mg (1.6 mmol) calcium carbonate. Each 250 mg +133.5 mg tablet contains 80 mg (0.8 mmol) calcium carbonate. Each dose of 10 ml of suspension contains 160 mg (1.6 mmol) calcium carbonate. Each sachet single dose of powder for oral administration from 500 mg + 267 mg contains 160 mg (1.6 mmol) calcium carbonate. You should pay attention in the treatment of patients with hypercalcemia, nephrocalcinosi and recurrent kidney stones containing calcium. Tablets and powder for oral administration contain aspartame, a source of phenylalanine: should not be taken from patients suffering from phenylketonuria. The suspension contains hydroxybenzoate and propyl paraidrossibenzoate, which may cause allergic reactions. As a rule, delayed-type reactions occur (contact dermatitis); rarely, immediate-type reactions with urticaria and bronchospasm occur. Duration of treatment If symptoms do not improve after seven days, the clinical picture should be re-evaluated.”